---
document_datetime: 2023-09-21 17:01:02
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/kisqali-epar-all-authorised-presentations_en.pdf
document_name: kisqali-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4819643
conversion_datetime: 2025-12-27 09:21:06.115027
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate packaging   | Pack size                        |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|----------------------------------|
| EU/1/17/1221/001 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 21 tablets                       |
| EU/1/17/1221/002 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PA/alu/PVC)  | 21 tablets                       |
| EU/1/17/1221/003 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 42 tablets                       |
| EU/1/17/1221/004 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PA/alu/PVC)  | 42 tablets                       |
| EU/1/17/1221/005 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 63 tablets                       |
| EU/1/17/1221/006 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PA/alu/PVC)  | 63 tablets                       |
| EU/1/17/1221/007 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 63 (3 x 21) tablets (multipack)  |
| EU/1/17/1221/008 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PA/alu/PVC)  | 63 (3 x 21) tablets (multipack)  |
| EU/1/17/1221/009 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 126 (3 x 42) tablets (multipack) |
| EU/1/17/1221/010 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PA/alu/PVC)  | 126 (3 x 42) tablets (multipack) |
| EU/1/17/1221/011 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 189 (3 x 63) tablets (multipack) |
| EU/1/17/1221/012 | Kisqali           | 200 mg     | Film-coated tablet    | Oral use                  | blister (PA/alu/PVC)  | 189 (3 x 63) tablets (multipack) |